146 related articles for article (PubMed ID: 32331991)
1. SUMOylation, a multifaceted regulatory mechanism in the pancreatic beta cells.
Li N; Zhang S; Xiong F; Eizirik DL; Wang CY
Semin Cell Dev Biol; 2020 Jul; 103():51-58. PubMed ID: 32331991
[TBL] [Abstract][Full Text] [Related]
2. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
[TBL] [Abstract][Full Text] [Related]
3. A post-translational balancing act: the good and the bad of SUMOylation in pancreatic islets.
MacDonald PE
Diabetologia; 2018 Apr; 61(4):775-779. PubMed ID: 29330559
[TBL] [Abstract][Full Text] [Related]
4. Sumoylation modulates oxidative stress relevant to the viability and functionality of pancreatic beta cells.
Yang P; Hu S; Yang F; Guan XQ; Wang SQ; Zhu P; Xiong F; Zhang S; Xu J; Yu QL; Wang CY
Am J Transl Res; 2014; 6(4):353-60. PubMed ID: 25075252
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation: A critical transcription modulator in plant cells.
Han D; Lai J; Yang C
Plant Sci; 2021 Sep; 310():110987. PubMed ID: 34315601
[TBL] [Abstract][Full Text] [Related]
6. Autophagy in health and disease. 4. The role of pancreatic beta-cell autophagy in health and diabetes.
Fujitani Y; Ueno T; Watada H
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C1-6. PubMed ID: 20457840
[TBL] [Abstract][Full Text] [Related]
7. Protein SUMOylation regulates insulin secretion at multiple stages.
Davey JS; Carmichael RE; Craig TJ
Sci Rep; 2019 Feb; 9(1):2895. PubMed ID: 30814610
[TBL] [Abstract][Full Text] [Related]
8. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
Onishi S; Kataoka K
J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
[TBL] [Abstract][Full Text] [Related]
9. The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation.
Gao J; Shao K; Chen X; Li Z; Liu Z; Yu Z; Aung LHH; Wang Y; Li P
J Mol Cell Cardiol; 2020 Jan; 138():49-58. PubMed ID: 31751566
[TBL] [Abstract][Full Text] [Related]
10. Impact of posttranslational modifications in pancreatic carcinogenesis and treatments.
Chen N; Zheng Q; Wan G; Guo F; Zeng X; Shi P
Cancer Metastasis Rev; 2021 Sep; 40(3):739-759. PubMed ID: 34342796
[TBL] [Abstract][Full Text] [Related]
11. Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance.
Usui M; Yamaguchi S; Tanji Y; Tominaga R; Ishigaki Y; Fukumoto M; Katagiri H; Mori K; Oka Y; Ishihara H
Metabolism; 2012 Aug; 61(8):1118-28. PubMed ID: 22386934
[TBL] [Abstract][Full Text] [Related]
12. Nuclear import of glucokinase in pancreatic beta-cells is mediated by a nuclear localization signal and modulated by SUMOylation.
Johansson BB; Fjeld K; Solheim MH; Shirakawa J; Zhang E; Keindl M; Hu J; Lindqvist A; Døskeland A; Mellgren G; Flatmark T; Njølstad PR; Kulkarni RN; Wierup N; Aukrust I; Bjørkhaug L
Mol Cell Endocrinol; 2017 Oct; 454():146-157. PubMed ID: 28648619
[TBL] [Abstract][Full Text] [Related]
13. The Role of Oxidative Stress in Pancreatic β Cell Dysfunction in Diabetes.
Eguchi N; Vaziri ND; Dafoe DC; Ichii H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546200
[TBL] [Abstract][Full Text] [Related]
14. Targeting SUMOylation cascade for diabetes management.
Sireesh D; Bhakkiyalakshmi E; Ramkumar KM; Rathinakumar S; Jennifer PS; Rajaguru P; Paulmurugan R
Curr Drug Targets; 2014; 15(12):1094-106. PubMed ID: 25230117
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin secretion by the post-translational modifications.
Yang C; Wei M; Zhao Y; Yang Z; Song M; Mi J; Yang X; Tian G
Front Cell Dev Biol; 2023; 11():1217189. PubMed ID: 37601108
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation of pancreatic glucokinase regulates its cellular stability and activity.
Aukrust I; Bjørkhaug L; Negahdar M; Molnes J; Johansson BB; Müller Y; Haas W; Gygi SP; Søvik O; Flatmark T; Kulkarni RN; Njølstad PR
J Biol Chem; 2013 Feb; 288(8):5951-62. PubMed ID: 23297408
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
18. Post-translational modification control of RNA-binding protein hnRNPK function.
Xu Y; Wu W; Han Q; Wang Y; Li C; Zhang P; Xu H
Open Biol; 2019 Mar; 9(3):180239. PubMed ID: 30836866
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of SUMO in pancreatic beta-cells.
Ehninger A; Mziaut H; Solimena M
Horm Metab Res; 2007 Sep; 39(9):658-64. PubMed ID: 17846973
[TBL] [Abstract][Full Text] [Related]
20. ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stress.
Yamaguchi S; Ishihara H; Yamada T; Tamura A; Usui M; Tominaga R; Munakata Y; Satake C; Katagiri H; Tashiro F; Aburatani H; Tsukiyama-Kohara K; Miyazaki J; Sonenberg N; Oka Y
Cell Metab; 2008 Mar; 7(3):269-76. PubMed ID: 18316032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
